Survival, persistence, and isolation of the emerging multidrug-resistant pathogenic yeast Candida auris on a plastic health care surface

Journal of Clinical Microbiology

Volumn 55, Issue 10, 2017, Pages 2996-3005

  Welsh, Rory M ^a   Bentz, Meghan L ^a   Shams, Alicia ^a   Houston, Hollis ^a   Lyons, Amanda ^a   Rose, Laura J ^a   Litvintseva, Anastasia P ^a  

^a NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

Author keywords

Candida; Candida auris; Candida parapsilosis; Clinical methods; Persistence; Public health

Indexed keywords

ESTERASE; PLASTIC; ANTIFUNGAL AGENT;

ARTICLE; CANDIDA; CANDIDA AURIS; CANDIDA PARAPSILOSIS; CONTROLLED STUDY; ENRICHMENT CULTURE; FUNGUS CULTURE; FUNGUS GROWTH; FUNGUS IDENTIFICATION; FUNGUS ISOLATION; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; SURFACE PROPERTY; SURVIVAL TIME; ANTIFUNGAL RESISTANCE; CANDIDIASIS; CROSS INFECTION; GROWTH, DEVELOPMENT AND AGING; HUMAN; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; TRANSMISSION;

ANTIFUNGAL AGENTS; CANDIDA; CANDIDA PARAPSILOSIS; CANDIDIASIS; CROSS INFECTION; DRUG RESISTANCE, FUNGAL; HUMANS; MICROBIAL SENSITIVITY TESTS; PLASTICS;

EID: 85030086698     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.00921-17     Document Type: Article

References (32)

1. Satoh K, Makimura K, Hasumi Y, Nishiyama Y, Uchida K, Yamaguchi H. 2009. Candida auris sp. nov., a novel ascomycetous yeast isolated from the external ear canal of an inpatient in a Japanese hospital. Microbiol Immunol 53:41-44. https://doi.org/10.1111/j.1348-0421.2008.00083.x.
2. Lee WG, Shin JH, Uh Y, Kang MG, Kim SH, Park KH, Jang HC. 2011. First three reported cases of nosocomial fungemia caused by Candida auris. J Clin Microbiol 49:3139-3142. https://doi.org/10.1128/JCM.00319-11.
3. Vallabhaneni S, Kallen A, Tsay S, Chow N, Welsh R, Kerins J, Kemble SK, Pacilli M, Black SR, Landon E, Ridgway J, Palmore TN, Zelzany A, Adams EH, Quinn M, Chaturvedi S, Greenko J, Fernandez R, Southwick K, Furuya EY, Calfee DP, Hamula C, Patel G, Barrett P, Lafaro P, Berkow EL, Moulton-Meissner H, Noble-Wang J, Fagan RP, Jackson BR, Lockhart SR, Litvintseva AP, Chiller TM. 2016. Investigation of the first seven reported cases of Candida auris, a globally emerging invasive, multidrug-resistant fungus-United States, May 2013-August 2016. MMWR Morb Mortal Wkly Rep 65:1234-1237. https://doi.org/10.15585/mmwr.mm6544e1.
4. Clancy CJ, Nguyen MH. 2016. Emergence of Candida auris: an international call to arms. Clin Infect Dis https://doi.org/10.1093/cid/ciw696.
5. Morales-López SE, Parra-Giraldo CM, Ceballos-Garzón A, Martínez HP, Rodríguez GJ, Álvarez-Moreno CA, Rodríguez JY. 2017. Invasive infections with multidrug-resistant yeast Candida auris, Colombia. Emerg Infect Dis 23:162. https://doi.org/10.3201/eid2301.161497.
6. Calvo B, Melo AS, Perozo-Mena A, Hernandez M, Francisco EC, Hagen F, Meis JF, Colombo AL. 2016. First report of Candida auris in America: clinical and microbiological aspects of 18 episodes of candidemia. J Infect 73:369-374. https://doi.org/10.1016/j.jinf.2016.07.008.
7. Ben-Ami R, Berman J, Novikov A, Bash E, Shachor-Meyouhas Y, Zakin S, Maor Y, Tarabia J, Schechner V, Adler A. 2017. Multidrug-resistant Candida haemulonii and C. auris, Tel Aviv, Israel. Emerg Infect Dis 23:195. https://doi.org/10.3201/eid2302.161486.
8. Schelenz S, Hagen F, Rhodes JL, Abdolrasouli A, Chowdhary A, Hall A, Ryan L, Shackleton J, Trimlett R, Meis JF. 2016. First hospital outbreak of the globally emerging Candida auris in a European hospital. Antimicrob Resist Infect Control 5:35. https://doi.org/10.1186/s13756-016-0132-5.
9. Lockhart SR, Etienne KA, Vallabhaneni S, Farooqi J, Chowdhary A, Govender NP, Colombo AL, Calvo B, Cuomo CA, Desjardins CA, Berkow EL, Castanheira M, Magobo RE, Jabeen K, Asghar RJ, Meis JF, Jackson B, Chiller T, Litvintseva AP. 2016. Simultaneous emergence of multidrugresistant Candida auris on three continents confirmed by whole-genome sequencing and epidemiological analyses. Clin Infect Dis https://doi.org/10.1093/cid/ciw691.
10. Chowdhary A, Sharma C, Duggal S, Agarwal K, Prakash A, Singh PK, Jain S, Kathuria S, Randhawa HS, Hagen F, Meis JF. 2013. New clonal strain of Candida auris, Delhi, India. Emerg Infect Dis 19:1670-1673. https://doi.org/10.3201/eid1910.130393.
11. Chakrabarti A, Sood P, Rudramurthy SM, Chen S, Kaur H, Capoor M, Chhina D, Rao R, Eshwara VK, Xess I, Kindo AJ, Umabala P, Savio J, Patel A, Ray U, Mohan S, Iyer R, Chander J, Arora A, Sardana R, Roy I, Appalaraju B, Sharma A, Shetty A, Khanna N, Marak R, Biswas S, Das S, Harish BN, Joshi S, Mendiratta D. 2015. Incidence, characteristics and outcome of ICU-acquired candidemia in India. Intensive Care Med 41: 285-295. https://doi.org/10.1007/s00134-014-3603-2.
12. Trofa D, Gacser A, Nosanchuk JD. 2008. Candida parapsilosis, an emerging fungal pathogen. Clin Microbiol Rev 21:606-625. https://doi.org/10.1128/CMR.00013-08.
13. Sanchez V, Vazquez JA, Barth-Jones D, Dembry L, Sobel JD, Zervos MJ. 1993. Nosocomial acquisition of Candida parapsilosis: an epidemiologic study. Am J Med 94:577-582. https://doi.org/10.1016/0002-9343 (93)90207-6.
14. Traore O, Springthorpe VS, Sattar SA. 2002. A quantitative study of the survival of two species of Candida on porous and nonporous environmental surfaces and hands. J Appl Microbiol 92:549-555. https://doi.org/10.1046/j.1365-2672.2002.01560.x.
15. De Bernardis F, Mondello F, San Millan R, Ponton J, Cassone A. 1999. Biotyping and virulence properties of skin isolates of Candida parapsilosis. J Clin Microbiol 37:3481-3486.
16. Guinea J. 2014. Global trends in the distribution of Candida species causing candidemia. Clin Microbiol Infect 20(Suppl 6):S5-S10. https://doi.org/10.1111/1469-0691.12539.
17. Pammi M, Holland L, Butler G, Gacser A, Bliss JM. 2013. Candida parapsilosis is a significant neonatal pathogen: a systematic review and metaanalysis. Pediatr Infect Dis J 32:e206-216. https://doi.org/10.1097/INF.0b013e3182863a1c.
18. van Asbeck EC, Huang YC, Markham AN, Clemons KV, Stevens DA. 2007. Candida parapsilosis fungemia in neonates: genotyping results suggest healthcare workers hands as source, and review of published studies. Mycopathologia 164:287-293. https://doi.org/10.1007/s11046-007-9054-3.
19. Smith R, Von Tress M, Tubb C, Vanhaecke E. 2010. Evaluation of the ScanRDI(R) as a rapid alternative to the pharmacopoeial sterility test method: comparison of the limits of detection. PDA J Pharm Sci Technol 64:356-363.
20. Epalle T, Girardot F, Allegra S, Maurice-Blanc C, Garraud O, Riffard S. 2015. Viable but not culturable forms of Legionella pneumophila generated after heat shock treatment are infectious for macrophage-like and alveolar epithelial cells after resuscitation on Candida auris for the clinical microbiology laboratory: not your grandfather's Candida species. Microb Ecol 69:215-224. https://doi.org/10.1007/s00248-014-0470-x.
21. Pinto D, Almeida V, Almeida Santos M, Chambel L. 2011. Resuscitation of Escherichia coli VBNC cells depends on a variety of environmental or chemical stimuli. J Appl Microbiol 110:1601-1611. https://doi.org/10.1111/j.1365-2672.2011.05016.x.
22. Colwell R, Brayton P, Grimes D, Roszak D, Huq S, Palmer L. 1985. Viable but non-culturable Vibrio cholerae and related pathogens in the environment: implications for release of genetically engineered microorganisms. Nat Biotechnol 3:817-820. https://doi.org/10.1038/nbt0985-817.
23. You R, Cui W, Chen C, Zhao B. 2013. Measuring the short-term emission rates of particles in the "personal cloud" with different clothes and activity intensities in a sealed chamber. Aerosol Air Qual Res 13:911-921.
24. Bhangar S, Adams RI, Pasut W, Huffman J, Arens EA, Taylor JW, Bruns TD, Nazaroff WW. 2016. Chamber bioaerosol study: human emissions of size-resolved fluorescent biological aerosol particles. Indoor Air 26: 193-206. https://doi.org/10.1111/ina.12195.
25. Sarvikivi E, Lyytikäinen O, Soll DR, Pujol C, Pfaller MA, Richardson M, Koukila-Kähkölä P, Luukkainen P, Saxén H. 2005. Emergence of fluconazole resistance in a Candida parapsilosis strain that caused infections in a neonatal intensive care unit. J Clin Microbiol 43:2729-2735. https://doi.org/10.1128/JCM.43.6.2729-2735.2005.
26. Moudgal V, Little T, Boikov D, Vazquez JA. 2005. Multiechinocandin-and multiazole-resistant Candida parapsilosis isolates serially obtained during therapy for prosthetic valve endocarditis. Antimicrob Agents Chemother 49:767-769. https://doi.org/10.1128/AAC.49.2.767-769.2005.
27. Neely AN, Maley MP. 2000. Survival of enterococci and staphylococci on hospital fabrics and plastic. J Clin Microbiol 38:724-726.
28. Costanzo SP, Borazjani RN, McCormick PJ. 2002. Validation of the Scan RDI for routine microbiological analysis of process water. PDA J Pharm Sci Technol 56:206-219.
29. Shams AM, Rose LJ, Edwards JR, Cali S, Harris AD, Jacob JT, LaFae A, Pineles LL, Thom KA, McDonald LC. 2016. Assessment of the overall and multidrug-resistant organism bioburden on environmental surfaces in healthcare facilities. Infect Cont Hosp Epidemiol 37:1426-1432. https://doi.org/10.1017/ice.2016.198.
30. Fraser M, Brown Z, Houldsworth M, Borman AM, Johnson EM. 2016. Rapid identification of 6328 isolates of pathogenic yeasts using MALDITOF MS and a simplified, rapid extraction procedure that is compatible with the Bruker Biotyper platform and database. Med Mycol 54:80-88.
31. Janda JM, Lopez DL. 2017. Mini review: new pathogen profiles: Elizabethkingia anophelis. Diagn Microbiol Infect Dis 88:201-205. https://doi.org/10.1016/j.diagmicrobio.2017.03.007.
32. Lockhart SR, Berkow EL, Chow N, Welsh RM. 2017. Candida auris for the clinical microbiology laboratory: not your grandfather's Candida species. Clin Microbiol Newsletter 39:99-103. https://doi.org/10.1016/j.clinmicnews.2017.06.003.